Article thumbnail

Balancing risk in ophthalmic prescribing: assessing the safety of anti-VEGF therapies and the risks associated with unlicensed medicines

By Peter K. Kaiser, Alan F. Cruess, Peter Bogaert, Kamlesh Khunti and Simon P. Kelly
Publisher: Springer Nature
Year: 2012
DOI identifier: 10.1007/s00417-012-2123-4
OAI identifier:

Suggested articles


To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.